Hematologic Toxicity of Antiretroviral Drug, Zidolam (zidovudine and lamivudine) in Adult Wistar Rats

Authors

  • OA Osonuga Department of Pharmacology, School of Medical Sciences, University of Cape Coast
  • OI Osonuga Department of Physiology, Olabisi Onabanjo University, Remo Campus, Ikenne Remo
  • AA Osonuga School of Medical Sciences, University of Cape Coast
  • A Osonuga Department of Nursing, University of Cape coast, Cape coast

DOI:

https://doi.org/10.3126/ajms.v1i2.3352

Keywords:

Zidolam, hematology, wistar rats, Highly active antiretroviral combination therapy (HAART)

Abstract

Objective: Zidolam is an highly active antiretroviral combination therapy (HAART) for the treatment of HIV infection. Efforts in this study intend to buttress evidence of hemato-toxicity associated with administration of HAARTs by using Zidolam.
Material & Methods: 30 albino rats with body weight (bwt) of 150 - 230 gm were used for the 2-phase study. Solution of the drug in sterile water was administered via oral cannula to the 2 groups of 10 rats (5 males and 5 females) each at daily dose of 1.29mg/100gm bwt respectively for 21 days during phase I. Phase II was a recovery study involving 10 rats (5 males and 5 females) exposed to dose regimen as in phase I, and sacrificed after 21-days withdrawal of treatment. The control group of 10 animals (5 males and 5 females) was given sterile water ad-libitum. Blood samples were collected by cardio-puncture from the rats for hematology at the end of each phase.
Results: Zidolam caused significant reduction (P< 0.05) in the hematological parameters of the animals. Discontinuation of the drug use caused gradual restoration of the parameters in the recovery group.
Conclusion: The results suggested that Zidolam could induce anemia and leucopenia in the treated animals. This supports the reason it is used with caution in anemic and leucopenic patients with HIV infection and perhaps reason for pre-hematological screening before treatment with zidolam.

Key Words: Zidolam; hematology; wistar rats; Highly active antiretroviral combination therapy (HAART)

DOI: 10.3126/ajms.v1i2.3352

Asian Journal of Medical Sciences 1 (2010) 41-44

Downloads

Download data is not yet available.
Abstract
1031
PDF
1268

Author Biography

OA Osonuga, Department of Pharmacology, School of Medical Sciences, University of Cape Coast

Downloads

Published

2011-01-14

How to Cite

Osonuga, O., Osonuga, O., Osonuga, A., & Osonuga, A. (2011). Hematologic Toxicity of Antiretroviral Drug, Zidolam (zidovudine and lamivudine) in Adult Wistar Rats. Asian Journal of Medical Sciences, 1(2), 41–44. https://doi.org/10.3126/ajms.v1i2.3352

Issue

Vol. 1 No. 2 (2010)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).